> push not the best, but the most profitable solutions Don’t you think that cocktails of novel antiviral drugs are a higher profit margin solution then the vac

> push not the best, but the most profitable solutions Don’t you think that cocktails of novel antiviral drugs are a higher profit margin solution then the vaccines that are already available? A remdesivir course costs almost two orders of magnitude more than an mRNA vaccine (in the US). Can’t really imagine these novel antiviral drugs will be much more affordable. To be clear, I do think both are important tools that we should use. Is there some other pragmatic solution you have in mind?